No connection

Search Results

ACHC vs AHG

ACHC
Acadia Healthcare Company, Inc.
BEARISH
Price
$23.52
Market Cap
$2.17B
Sector
Healthcare
AI Confidence
85%
AHG
Akso Health Group
BEARISH
Price
$2.50
Market Cap
$2.14B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ACHC
--
AHG
--
Forward P/E
ACHC
14.03
AHG
--
P/B Ratio
ACHC
1.09
AHG
10.82
P/S Ratio
ACHC
0.65
AHG
144.3
EV/EBITDA
ACHC
8.46
AHG
-4387.63

Profitability

Gross Margin
ACHC
41.48%
AHG
1.0%
Operating Margin
ACHC
5.8%
AHG
-20.54%
Profit Margin
ACHC
-33.29%
AHG
0.0%
ROE
ACHC
-40.96%
AHG
-68.29%
ROA
ACHC
4.22%
AHG
-1.42%

Growth

Revenue Growth
ACHC
6.1%
AHG
0.9%
Earnings Growth
ACHC
--
AHG
--

Financial Health

Debt/Equity
ACHC
1.24
AHG
0.01
Current Ratio
ACHC
1.55
AHG
1.53
Quick Ratio
ACHC
1.29
AHG
1.19

Dividends

Dividend Yield
ACHC
--
AHG
--
Payout Ratio
ACHC
0.0%
AHG
0.0%

AI Verdict

ACHC BEARISH

ACHC's Piotroski F-Score of 2/9 indicates severe financial distress, with weak profitability, declining earnings, and high leverage. The absence of an Altman Z-Score and negative ROE (-40.96%) raise significant bankruptcy risk concerns. Despite a modest forward P/E of 14.03 and strong recent earnings surprises, the company's negative profit margin (-33.29%) and massive year-over-year EPS decline (-89.1%) undermine its fundamentals. The stock's 5-year price drop of 61.4% and lack of dividend support further signal investor skepticism. Analysts recommend 'buy' but with limited conviction, as the underlying financial health remains fragile.

Strengths
Recent quarterly earnings have consistently beaten estimates (3/4 in last 4 quarters)
Strong average earnings surprise of 206.53% over the last 4 quarters
Positive revenue growth of 6.10% YoY, outpacing many peers
Risks
Piotroski F-Score of 2/9 signals extreme financial weakness and high distress risk
Negative profit margin (-33.29%) and ROE (-40.96%) reflect deep profitability issues
Debt/Equity ratio of 1.24 is elevated for a healthcare facility operator, especially with negative earnings
AHG BEARISH

AHG's Piotroski F-Score of 5/9 indicates a stable but not strong financial position, with significant red flags in profitability and cash flow. The company reports a 0.00% profit margin, negative ROE of -68.29%, and a gross margin of just 1.00%, signaling deep operational inefficiencies. Despite a low debt/equity ratio and decent liquidity, the absence of positive earnings, free cash flow, and a lack of dividend support undermine long-term sustainability. The stock's price performance is driven by speculative momentum rather than fundamentals, with a Price/Sales of 144.30 far exceeding sector averages and no intrinsic value support.

Strengths
Low debt/equity ratio (0.01) indicates minimal financial leverage risk
Current ratio of 1.53 and quick ratio of 1.19 suggest adequate short-term liquidity
Recent price surge (85.2% in 1 week) reflects strong short-term market momentum
Risks
Negative ROE (-68.29%) and ROA (-1.42%) indicate severe capital inefficiency and losses
0.00% profit margin and -20.54% operating margin reveal fundamental business model flaws
No free cash flow or operating cash flow data available, raising liquidity sustainability concerns

Compare Another Pair

ACHC vs AHG: Head-to-Head Comparison

This page compares Acadia Healthcare Company, Inc. (ACHC) and Akso Health Group (AHG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile